✦ LIBER ✦

Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease

✍ Scribed by M Riekkinen; H Soininen; P Riekkinen Sr; J Kuikka; M Laakso; E.-L Helkala; J Partanen; P Riekkinen Jr

Book ID: 117492132
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 116 KB
Volume: 83
Category: Article
ISSN: 0306-4522
DOI: 10.1016/s0306-4522(97)00400-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tetrahydroaminoacridine in Alzheimer's d

Tetrahydroaminoacridine in Alzheimer's disease

✍ B. Davies; D. Andrewes; R. Stargatt; D. Ames; V. Tuckwell; S. Davis 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 445 KB 👁 1 views

Tetrahydroaminoacridine (THA), a centrally acting anticholinesterase, was used in a two-month, double-blind, placebo-controlled crossover trial to treat 10 patients meeting DSM-111-R criteria for dementia of the Alzheimer type. Eight patients continued to take THA for a further three months. Nausea

ALZHEIMER'S DISEASE AND TETRAHYDROAMINOA

ALZHEIMER'S DISEASE AND TETRAHYDROAMINOACRIDINE

✍ Whitford, G.M. 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 176 KB

TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S

TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S DISEASE

✍ Levy, Raymond 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 153 KB

TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S

TETRAHYDROAMINOACRIDINE AND ALZHEIMER'S DISEASE

✍ Katona, CorneliusL.E.; O'Brien, Catherine; Tyrrell, P.; Hardy, J.; Rossor, M.; W 📂 Article 📅 1987 🏛 The Lancet 🌐 English ⚖ 347 KB

The effect of tetrahydroaminoacridine (T

The effect of tetrahydroaminoacridine (THA) on P300 in Alzheimer's disease

✍ Willem A. van Gool; Jozef Waardenburg; F. Eelco Posthumus Meyjes; Henry C. Weins 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 286 KB

Tetrahydroaminoacridine and lecithin in

Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease

✍ Henry C. Weinstein; Saskia Teunisse; Willem A. Gool 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 529 KB

In 12 ambulant patients with a clinical diagnosis of probable Alzheimer's disease, a 12-week, double-blind, placebo-controlled study with 100 mg/day tetrahydroaminoacridine (THA) and 10 g/day lecithin is reported. The aim of the study was to find whether treatment would result in an improvement of c